Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
Surprising Drug Approval: Time to Buy? (video)
Motley Fool
Sun, 06/1/14 - 11:26 am
multiple sclerosis
MS
PTC Therapeutics
Translarna
[video]Supreme Court + Risky Drug Launch = Billions at Stake
Motley Fool
Fri, 05/30/14 - 12:25 pm
Supreme Court
Teva Pharmaceuticals
Copaxone
generics
MS
multiple sclerosis
Generic Copaxone approval very unlikely this quarter, says Jefferies
The Fly on the Wall
Wed, 05/28/14 - 09:24 am
generics
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Teva, Active Biotech to continue development of Nerventra
The Fly on the Wall
Fri, 05/23/14 - 07:00 am
Teva Pharmaceuticals
Nerventra
Active Biotech
MS
multiple sclerosis
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thu, 05/15/14 - 07:35 am
Teva
FDA
generics
Copaxone
Mylan Labs
Novartis
Sandoz
multiple sclerosis
Inovio acquires early stage DNA therapies to treat Alzheimer's, MS
The Fly on the Wall
Tue, 05/13/14 - 07:58 am
DNA
Inovio
Alzheimer's disease
MS
multiple sclerosis
Sanofi's MS team rebuilds its case for the FDA-rejected MS drug Lemtrada
Fierce Biotech
Thu, 05/1/14 - 08:41 am
Lemtrada
Sanofi
MS
multiple sclerosis
Teva Rejected by Supreme Court on Generic Copaxone Delay
Bloomberg
Fri, 04/18/14 - 04:35 pm
Teva Pharmaceuticals
generics
Supreme Court
Copaxone
patents
MS
multiple sclerosis
Generic Drugmakers Fight Teva’s Bid to Stall Competition
Wall St Cheat Sheet
Thu, 04/17/14 - 10:57 am
generics
Teva
Copaxone
MS
multiple sclerosis
Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Mon, 04/14/14 - 07:08 pm
Teva
Copaxone
MS
multiple sclerosis
Momenta
generics
Sandoz
Mylan
Biogen Idec May Have Seeds For Next-Gen MS Drugs
Investors.com
Mon, 04/7/14 - 05:08 pm
MS
Biogen Idec
multiple sclerosis
BIIB-061
remylination
Tecfidera
Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review
Yahoo
Mon, 04/7/14 - 08:47 am
Sanofi
Genzyme
Lemtrada
FDA
MS
multiple sclerosis
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Mon, 03/31/14 - 11:00 am
Supreme Court
MS
multiple sclerosis
Copaxone
Teva Pharmaceuticals
Sandoz
Mylan
Momenta
U.S. top court takes no action in Teva MS drug case
Reuters
Mon, 03/24/14 - 12:14 pm
Teva Pharmaceuticals
MS
multiple sclerosis
generics
Copaxone
FDA delays decision on Biogen's multiple sclerosis drug
Yahoo/Reuters
Tue, 03/18/14 - 08:58 am
FDA
Plegridy
Biogen Idec
MS
multiple sclerosis
Teva Copaxone Appeal Action Delayed by U.S. Supreme Court
Bloomberg
Mon, 03/10/14 - 04:04 pm
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Merck shores up Rebif defenses to fend off new MS rivals
Fierce Pharma
Thu, 03/6/14 - 11:34 am
Rebif
MS
multiple sclerosis
Merck KGaA
Teva’s New Version of Copaxone Could Be a Tough Bet for Insurers
Wall St Cheat Sheet
Tue, 03/4/14 - 08:30 am
Teva Pharmaceuticals
Copaxone
insurance
MS
multiple sclerosis
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera
Investors.com
Mon, 03/3/14 - 03:34 pm
Tecfidera
MS
multiple sclerosis
Biogen Idec
Teva Braces for Tussle With Insurers Over Copaxone’s Heir
Bloomberg
Mon, 03/3/14 - 08:28 am
Teva
Copaxone
MS
multiple sclerosis
generics
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »